Status:

RECRUITING

Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)

Lead Sponsor:

Changhai Hospital

Conditions:

Pancreatic Cancer

Diabetes

Eligibility:

All Genders

50-75 years

Brief Summary

Pancreatic cancer is one of the most fatal malignancies with a 5-year survival rate of only \~6%\[1\]. The reasons for this high mortality rate can be attributed to several factors, of which perhaps t...

Detailed Description

The study is being run by a team of dedicated physicians and researchers, led by Jin Gang, MD, Director of Department of general surgery of Shanghai Changhai Hospital. The trial will include individua...

Eligibility Criteria

Inclusion

  • Subject is able and willing to provide informed consent and sign an informed consent form.
  • Subject or authorized representative must be willing to complete a detailed questionnaire.
  • Subject must meet one of the following criteria:
  • New onset diabetes (diagnosed within the past 3 years)
  • Familial pancreatic cancer
  • Inherited syndromes associated with pancreatic cancer (including Hereditary pancreatitis, Familial atypical multiple mole and melanoma syndrome, Hereditary nonpolyposis colon cancer, Peutz-Jeghers syndrome, Hereditary breast and ovarian cancer syndromes, etc)
  • Pancreatic cystic neoplasm (including IPMN, MCN)
  • Chronic pancreatitis

Exclusion

  • Subject has been diagnosed with pancreatic cancer or other malignant tumors in the last 5 years;
  • Subject has any medical condition that contraindicates high-resolution MRI or CT;
  • Subject cannot be followed up or is participating in other clinical trials.

Key Trial Info

Start Date :

December 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 30 2030

Estimated Enrollment :

5000 Patients enrolled

Trial Details

Trial ID

NCT04743479

Start Date

December 1 2020

End Date

December 30 2030

Last Update

September 1 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shanghai Changhai Hospital

Shanghai, China, 200433